Pathophysiology of vascular disease in diabetes: Effects of gliclazide
- 24 June 1991
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 90 (6) , S50-S54
- https://doi.org/10.1016/0002-9343(91)90418-w
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effects of an oral antidiabetic drug on the fibrinolytic system of blood in insulin-treated diabetic patientsMetabolism, 1988
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988
- Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled studyDiabetes Research and Clinical Practice, 1988
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Effect of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetesThrombosis Research, 1984
- The effects of gliclazide on platelet function in patients with diabetes mellitusCurrent Medical Research and Opinion, 1982
- Atherosclerosis in diabetes mellitusJournal of Chronic Diseases, 1981
- Effects of diet and gliclazide on the haemostatic system of non-insulin-dependent diabetics.BMJ, 1981
- Pathogenesis of Atherosclerosis in Diabetes MellitusDiabetes Care, 1981
- Anti-platelet effects of long-term treatment with gliclazide in diabetic patientsThrombosis Research, 1979